Investigating breast cancer and atrial fibrillation overlap, this study highlights key risk factors, underscoring the need ...

Johnson & Johnson announced that the FDA approved its dual energy catheter ablation platform designed to deliver ...

Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased ...

Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) approved the Dual Energy THERMOCOOL SMARTTOUCH SF Platform (DE STSF), an integrated catheter ablation ...

U.S. electrophysiologists can now switch between radiofrequency and pulsed field energy in a single, fully integrated catheter when they use Johnson & Johnson’s Dual Energy Thermocool Smarttouch SF ...

Johnson & Johnson advances cardiac ablation technology in Europe with availability of Dual Energy THERMOCOOL SMARTTOUCH SF Platform.

Johnson & Johnson introduces India’s first Pulsed Field Ablation technology, VARIPULSE™, revolutionizing atrial fibrillation ...

To have here Michael Bodner, Company Group Chair, EP and Neurovascular from J&J MedTech as well as Ryan and Lauren from Investor Relations. So thank you so much for being here. Just a quick background ...

The new Cartosound Sonatamodule integrates with the company’s CARTO System to convert intracardiac echocardiography images into detailed maps and automatically label cardiac structures. The tool is ...

Johnson & Johnson today announced it will showcase the latest advances across its electrophysiology portfolio at the 2026 Heart Rhythm Society (HRS) Annual Meeting, including new evidence in pulsed ...

IRVINE, Calif.--(BUSINESS WIRE)-- Johnson & Johnson today announced it will showcase the latest advances across its electrophysiology portfolio at the 2026 Heart Rhythm Society (HRS) Annual Meeting, ...